Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains

Etheresia Pretorius, Martin J. Page, Lize Engelbrecht, Graham C. Ellis, Douglas B. Kell
  • Cardiovascular Diabetology, November 2017, Springer Science + Business Media
  • DOI: 10.1186/s12933-017-0624-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Professor Douglas B Kell